Assessment of the efficacy and safety of antimicrobial lock solution of Ethanol-enoxaparin for the prevention of catheter-related infection in hematologic patients: A randomized, controlled, triple-blind clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 402 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•Hematologic malignancy or hematopoietic stem cell transplantation
•Recent insertion of the catheter (within the last 48 hours) in aseptic conditions of the operating room, and confirmation of its placement through radiography or radioscopy
•Informed consent from the patient or their legal guardian

•History of any allergy/sensitivity/intolerance to Ethanol or Enoxaparin
•Pregnancy or breastfeeding
•History of alcohol abuse
•History of thrombocytopenia caused by heparin (HIT) or having an active hypocoagulable state
•Evidence of catheter site infection
•Evidence of active systemic infection (fever, chills, positive culture and leukocytosis) or documented bacteremia within 24 hours before catheter placement
•Receiving antibiotic treatment
•Patients in need of dialysis modalities
•Cirrhosis of the liver
•Having a history or documented active seizure disorder
•Patients whose catheters are placed in emergency situations
•Patients in critical conditions (those who need continuous infusion of fluid/medicine through both lumens)

发起方